Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Information of IR re: the determination of the BoD-member number

Just think now, with a limit of five board seats, the announcement of a new CEO would provide strong justification for at least one of three BOD fixtures to resign. Then we would only have two more to sack before the shareholders would be given real consideration in company mattters.

Share
New Message
Please login to post a reply